Bobbydigitals picks

[bobbydigital]

My next big stock is MCUJ... Volume very slow today much like GBTR was for days before it ran. I was pounding the table on that stock and it didnt run until days later. PPS went from .02 to .61 in a matter of a week after the run began.

FWIW the O/S is the same now as it was back when it was $2. (Unlike 99.9% other stocks that drop in a similar manner)


MCUJ is one people wanna watch to accumulate. Read over this link and info. MCUJ was a $2 AMEX stock a few years back.. Stock plummeted after announcing negative results from its pivotal phase 3 trial of MC-1. O/S hasnt changed in all this time.. From there they ran into debt issues. On 7/18 they announced via PR they resolved $32M in debt they had. CEO said that was an issue that plagued them. Now with debt gone they can move forward with clinical trials that were on hold. This is the rebirth of MCUJ.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=65353658

finman1107/19/2011 12:02:46 PM | | 116 reads | Post #29986935

Want to know why this is flying?

The company is no longer faced with the possibiity of being taken over by its debtholders.

The company can continue its development of other drugs ... like Tardoxal which has no financing partner; announcing a financing partner could be the next big thing for the company.

It's hard to know what the company is worth right now.

Take a look at a chart that goes into 2007 ....

This thing used to trade around $1 with 120 Million Shares Outstanding.

Today we have 190 Million Shares (this includes the recent options).

With the company avoiding receivership, its obvious we are undervalued.

Maybe a $1 should not be expected by the end of the week, but I wonder what will be a decent price
.10?
.25? Maybe higher?

Watch as the news hits more traders.

A company that has a drug at market .... old debt problem resolved ... new drug that is in Phase 2 for a market with a value of 150 to 600 Million per year?

Old debt problem resolved .... new product that is in Phase 2 Trials ...... two additional drugs that have had development halted due to possible receivership.

I am loving this attempt to keep it canned at
.055 ..... Obviously someone is trying to get old traders to bail out.